Urinary MicroRNA Biomarkers of Nephrotoxicity in Macaca fascicularis.

extracellular vesicles microRNAs nephrotoxicity urine biomarkers

Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
25 Jun 2024
Historique:
received: 08 01 2024
revised: 10 06 2024
accepted: 24 06 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 27 6 2024
Statut: aheadofprint

Résumé

Drug-induced kidney injury (DIKI) refers to kidney damage resulting from the administration of medications. The aim of this project was to identify reliable urinary microRNA (miRNAs) biomarkers that can be used as potential predictors of DIKI before disease diagnosis. This study quantified a panel of six miRNAs (miRs-210-3p, 423-5p, 143-3p, 130b-3p, 486-5p, 193a-3p) across multiple time points using urinary samples from a previous investigation evaluating effects of a nephrotoxicant in cynomolgus monkeys. Exosome-associated miRNA exhibited distinctive trends when compared to miRNAs quantified in whole urine, which may reflect a different urinary excretion mechanism of miRNAs than those released passively into the urine. Although further research and mechanistic studies are required to elucidate how these miRNAs regulate signaling in disease pathways, we present, for the first time, data that several miRNAs displayed strong correlations with histopathology scores, thus indicating their potential use as biomarkers to predict the development of DIKI in preclinical studies and clinical trials. Also, these findings can potentially be translated into other non-clinical species or human for the detection of DIKI.

Identifiants

pubmed: 38936797
pii: S0273-2300(24)00109-0
doi: 10.1016/j.yrtph.2024.105668
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105668

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☒ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The following authors are employed in the pharmaceutical industries (at the time of article submission): P.K.M., B.B., A.E., E.V., T.S., D.D.W., A.S, T.R.V. The opinions presented here are those of the authors. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Subham Dasgupta (S)

Clemson University, Clemson, SC, USA.

Tatiana Sharapova (T)

AbbVie, North Chicago, IL, USA.

Prathap K Mahalingaiah (PK)

AbbVie, North Chicago, IL, USA.

Brian N Chorley (BN)

U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.

Ahmed Shoieb (A)

Former Pfizer DSRD. Groton, CT, USA.

Takayuki Tsuji (T)

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Alef A C Dos Santos (AAC)

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Rohit Chari (R)

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Ali Ebrahimi (A)

GSK, Collegeville, PA, USA.

Deidre A Dalmas Wilk (DA)

GSK, Collegeville, PA, USA.

Syril Pettit (S)

Health and Environmental Sciences Institute, Washington, DC, USA.

Bhupinder Bawa (B)

AbbVie, North Chicago, IL, USA.

Erin Vaughan (E)

AbbVie, North Chicago, IL, USA.

Terry R van Vleet (TR)

AbbVie, North Chicago, IL, USA.

Constance A Mitchell (CA)

Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cmitchell@hesiglobal.org.

Peter S T Yuen (PST)

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH